> Skip repeated content
photo of Allan Gibofsky, MD, JD, MACR, FACP, FCLM

Allan Gibofsky, MD, JD, MACR, FACP, FCLM


About Dr. Gibofsky

Dr. Allan Gibofsky has conducted extensive research on rheumatic fever and rheumatoid arthritis. He is a Professor of Medicine at Weill Cornell Medical College and an Attending Rheumatologist at Hospital for Special Surgery, where he is co-Director of the Clinic for Inflammatory Arthritis and Biologic Therapy.

Profile Video


Patient Stories


If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.



Attending Physician, Hospital for Special Surgery
Professor of Medicine, Weill Cornell Medical College


Internal Medicine


Master, The American College of Rheumatology, 2014
Castle Connolly Top Doctor - 20 Years
Castle Connolly Top Doctors in New York Metro Area, 2005-2022
New York Magazine Top Doctors, 2021, 2022


MD, Weill Cornell Medical School, New York

JD, Fordham University School of Law


The New York Hospital, New York


Hospital for Special Surgery - Rockefeller University

State Licensure



Publications by Dr. Gibofsky

Patient Education


Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

Below are the healthcare industry relationships reported by Dr. Gibofsky as of February 27, 2023.

  • AbbVie Inc. - Advisory Board; Consultant; Ownership Interest; Speakers' Bureau
  • Acquist (formerly Relburn Pharmaceuticals) - Advisory Board
  • American College of Rheumatology - Committee Member
  • Amgen - Consultant; Speakers’ Bureau
  • Boehringer Ingelheim - Author
  • Johnson & Johnson - Ownership Interest
  • Pfizer, Inc. - Advisory Board; Author; Consultant; Ownership Interest; Speakers' Bureau
  • Sahumed, LLC - Consultant
  • The Rheumatology Education Group - Speakers' Bureau
  • UptoDate - Author
  • US Food and Drug Administration - Consultant

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.

Patients should feel free to ask their HSS physicians questions about these relationships.

Dr. Gibofsky in the News